Cargando…

Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study

INTRODUCTION: The primary aim of this study was to compare the incidence of venous thromboembolism (VTE) among women initiating ospemifene vs other selective estrogen receptor modulator (SERM) therapies for estrogen-deficiency conditions or breast cancer prevention, and vs women with untreated vulva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nordstrom, Beth L., Cai, Bin, De Gregorio, Fabio, Ban, Lu, Fraeman, Kathy H., Yoshida, Yuki, Gibbs, Trevor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677319/ https://www.ncbi.nlm.nih.gov/pubmed/36420373 http://dx.doi.org/10.1177/20420986221135931

Ejemplares similares

Ospemifene for vulvar and vaginal atrophy: an overview
por: Palacios, Santiago
Publicado: (2020)

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy
por: Goldstein, S. R., et al.
Publicado: (2014)

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
por: Wurz, Gregory T, et al.
Publicado: (2014)

Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast
por: Soe, Lin H, et al.
Publicado: (2013)

Venous thromboembolism in women
por: Peclat, Ana Paula Rolim Maia, et al.
Publicado: (2023)

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy
por: Shin, Jae Jun, et al.
Publicado: (2017)

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices
por: Goldstein, Irwin, et al.
Publicado: (2019)

Venous thromboembolism: current management
por: Stevens, Hannah, et al.
Publicado: (2019)

Venous anomalies and thromboembolism
por: Dix, Caroline, et al.
Publicado: (2023)

The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy
por: Nappi, R. E., et al.
Publicado: (2015)

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy
por: Bruyniks, N., et al.
Publicado: (2016)

Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials
por: Simon, James A., et al.
Publicado: (2018)

Venous thromboembolism in transgender women
por: Marques, Marcos Arêas, et al.
Publicado: (2023)

Incidence of New-Onset Hypertension in Cancer Patients: A Retrospective Cohort Study
por: Fraeman, Kathy H., et al.
Publicado: (2013)

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial
por: Archer, David F., et al.
Publicado: (2019)

Use of Erythropoiesis-Stimulating Agents Among Chemotherapy Patients With Hemoglobin Exceeding 12 Grams Per Deciliter
por: Nordstrom, Beth L., et al.
Publicado: (2008)

Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases
por: Goldstein, Andrew T., et al.
Publicado: (2016)

Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study
por: Huang, Duo, et al.
Publicado: (2019)

Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Blanco-Molina, Angeles, et al.
Publicado: (2014)

Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care
por: Allende-Pérez, Silvia Rosa, et al.
Publicado: (2022)

Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study
por: Kitayama, Hiromitsu, et al.
Publicado: (2017)

Effect of Ospemifene on Densitometric and Plasma Bone Metabolism Biomarkers in Postmenopausal Women Reporting Vulvar and Vaginal Atrophy (VVA)
por: Maffei, Silvia, et al.
Publicado: (2022)

Endometrial safety of ospemifene: results of the phase 2/3 clinical development program
por: Constantine, Ginger D., et al.
Publicado: (2015)

Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy
por: Palacios, Santiago, et al.
Publicado: (2016)

Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies
por: Salcedo, Félix Lugo, et al.
Publicado: (2020)

Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study
por: Rodríguez, Silvia Pilar González
Publicado: (2020)

Experience with ospemifene in patients with vulvar and vaginal atrophy and urinary incontinence: case studies
por: Blanco, Zuramis Estrada, et al.
Publicado: (2020)

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis
por: Huang, Jimmy, et al.
Publicado: (2022)

Pulmonary Thromboembolism in COVID-19: Venous Thromboembolism or Arterial Thrombosis?
por: Cavagna, Enrico, et al.
Publicado: (2020)

Occurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network
por: Shantakumar, Sumitra, et al.
Publicado: (2016)

The risk of venous thromboembolism in cancer patients receiving chemotherapy: a meta-analysis with systematic review
por: Bao, Yun, et al.
Publicado: (2021)

Experience with ospemifene in patients with vulvar and vaginal atrophy and associated sexual dysfunction: case studies
por: López, Ana Rosa Jurado, et al.
Publicado: (2020)

Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles
por: del Carmen Pingarrón Santofimia, María, et al.
Publicado: (2020)

Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use
por: Cagnacci, Angelo, et al.
Publicado: (2020)

Venous thromboembolism in COVID-19 patients
por: Rossi, Fabio Henrique
Publicado: (2020)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial
por: Constantine, G., et al.
Publicado: (2015)

Venous thromboembolism in women: new challenges for an old disease
por: de Oliveira, André Luiz Malavasi Longo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_meo64ort7da7qdn1shmccdgq9q